Article Dump - Health and Fitness

There are over two million people in the US with Rheumatoid Arthritis (RA). Those who suffer with it experience pain and inflammation in their joints, accompanied by swelling, stiffness, fever and fatigue. If left untreated, it can progress to total dysfunction of the joints. Relief does appear to be close at hand, with a new generation of

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

treatments being trialed today.

The disease affects most people from middle age, but some children and young adults can face earlier onset (Juvenile Arthritis). Unlike Ankylosing Spondylitis, it affects double or more women than men. Rheumatoid arthritis usually affects both sides of the body, which is called having symmetrical symptoms.

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

his means if a person has it in one knee, they will have it in the other as well. It commonly affects the wrists and finger joints, but can be in any part of the body.

Some symptoms that aren't in the joints are anemia, a decrease in the production of red blood cells, muscular neck pain and dry eyes and mouth and, in some rare cases, inflam

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ed blood vessels and lining of the lungs or heart. Some people will have shorter flair ups of RA that last a month or two, while others can have longer periods with severe symptoms for years on end.

The longer Rheumatoid Arthritis is actively causing symptoms, it is also causing more irreparable damage and disability to its victims. Osteopo

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

osis is more prominent in long-term sufferers, which often means their bones will fracture very easily. Muscles that are used to support the joints are either weakened or suffer from over-use, causing referred pain and disability. As Rheumatoid Arthritis starts causing its damage very early on, rapid diagnosis is becoming prominently import

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

nt.

Rheumatoid Arthritis is a disease that affects the immune system, causing the body to turn against itself and attack healthy joint tissue. No specific cause has been identified, but it is believed that genetics, environment, hormones and stress levels can all have an impact. It is diagnosed with a combination of a physical examination

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

of the joints, reflexes, muscle stability and appearance of the skin, a blood test for white blood cell count and an x-ray that will show up any long-term joint damage.

Some patients may require surgery. This would not be a first option for most people and is usually joint replacement or tendon reconstruction surgery. Otherwise, treatment f

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

cuses on the right medication, regular rest, regular, appropriate exercise, healthy eating, increased awareness and psychological support. The aim is to take away the pain, eliminate swelling, discontinue or disable tissue destruction, maintain flexibility and minimize fatigue and stress factors.

In the past, the only treatments available f

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

r Rheumatoid Arthritis were aspirin, paracetamol and anti-inflammatory drugs that often contain steroids. Specialists would wait until the disease progressed to more advanced stages before prescribing anything more powerful. As it is now known that the damage is started much earlier on in its course, stronger treatments and combinations are

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

recommended to try to halt the progression and, hopefully, avoid disability later in life.

One powerful form of treatment is the Non-steroidal Anti-inflammatory Drugs (NSAIDs), which reduce pain and decrease inflammation. They can cause side effects such as an upset stomach, peptic ulcers, excessive bleeding and renal failure and a patient

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

annot drink any alcohol due to the extra strain they can place on the liver. Some examples are Ibuprofen, Ketoprofen and Naproxen. These are also used to treat Ankylosing Spondylitis, Juvenile Arthritis and Psoriasis.

Disease-modifying anti-rheumatic drugs (DMARDs) are also a common treatment and are known to reduce pain in swollen joints a

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

d retard joint damage. They can take between a few weeks or a few months to work and there are also side effects to consider.

Taking DMARDs can heighten the infection risk, cause loss of hair and possibly cause damage to the liver or kidneys. Methotrexate is a well-known DMARD and is administered orally or injected. It has been found espec

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ially effective when combined with the new generation treatment, ENBREL.

There have been countless medicines produced over the years in hope of helping those with Rheumatoid Arthritis, Ankylosing Spondylitis, Juvenile Arthritis and Psoriasis, but it is these new drugs that appear to possibly be on the track to providing relief.

Biologic res

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

onse modifiers are the current Rheumatic Arthritis drugs that have been showing great promise for patients. Clinical trials that have been underway have produced data which suggests they reduce inflammation and slow the progression of the disease and the damage it causes.

ENBREL (aka etanercept) works by stopping the over production of the

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ody's cytokines, which is the protein the immune system has been using to kill the healthy joint tissue. It is usually administered with a fortnightly injection.

The drug is a Tumor Necrosis Factor Inhibitor. RA sufferers are known to have too much TNFa being produced (as do those with Ankylosing Spondylitis, Juvenile Arthritis and Psorias

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

is) and when ENBREL and TNFa blocker protein reduces the cytokine levels, patients feel remarkable improvements.

The main side effect of taking ENBREL is a weakening of the immune system, so infections could potentially be fatal. It is for this reason doctors have to apply very strict screening for trail admissions, as anyone with an alread

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

compromised immunity can not possibly take it.

ENBREL's more minor side effects could be a sore, burning in the throat and/or a rash where the needle entered and/or a blocked, runny nose. Otherwise it is proving itself to possibly be the new revolutionary treatment to stop the progression of the disease.

Over the past twenty years or so,

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

large amount of research has been done on Rheumatoid Arthritis. Through experts increased awareness of how the immune system works and the role of genetics and human biology, RA treatments are being viewed with new and excited eyes.

Scientists are finding that combinations of treatments are better than one alone, such as ENBREL and methotr

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

exate, which can noticeably slow damage to joints. The aim for all involved in the search for the answer is to continue helping victims by relieving their pain, reducing inflammation and swelling, slow or stop damage to joints and restore their ability to function every day.

This can be achieved with ongoing monitoring of medication, lifesty

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

e and side effect management. If the need for surgery can be avoided or delayed, this is definitely a step in the right direction.

Disclaimer: The information presented here should not be interpreted as or substituted for medical advice. Please talk to a qualified professional for more information about Rheumatoid Arthritis

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.articledump.org.ua/article/241411/articledump-How-to-Fight-Rheumatoid-Arthritis.html">How to Fight Rheumatoid Arthritis</a>

BB link (for phorums):
[url=http://www.articledump.org.ua/article/241411/articledump-How-to-Fight-Rheumatoid-Arthritis.html]How to Fight Rheumatoid Arthritis[/url]

Learn how to use mantras to help your career. Whether you're looking for a new job, dealing with unemployment or trying to become a better manager, this article provides examples of mantras that have helped clients reach their career goals.

A first time buyer mortgage is truly unique in itself as it gives decent opportunity to a borrower to use the tied up equity of his newly bought home. Thus, this newly bought home is offered as collateral against the loan amount like a secured loan. A borrower enjoys some benefits with a first time buyer mortgage such as a low interest rate with small monthly repayments, which makes the repayment easier.

Are you concerned about the lack of after school activities at your child's school? Are you worried that he or she is being deprived of much extra knowledge and stimulation that these programs can provide? There are some things you can do.

Tags

Links

Article Dump - How to Fight Rheumatoid Arthritis

Related Articles: